The global burden of trichiasis in 2016.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
11 2019
Historique:
received: 25 04 2018
accepted: 08 10 2019
revised: 09 12 2019
pubmed: 26 11 2019
medline: 12 2 2020
entrez: 26 11 2019
Statut: epublish

Résumé

Trichiasis is present when one or more eyelashes touches the eye. Uncorrected, it can cause blindness. Accurate estimates of numbers affected, and their geographical distribution, help guide resource allocation. We obtained district-level trichiasis prevalence estimates in adults for 44 endemic and previously-endemic countries. We used (1) the most recent data for a district, if more than one estimate was available; (2) age- and sex-standardized corrections of historic estimates, where raw data were available; (3) historic estimates adjusted using a mean adjustment factor for districts where raw data were unavailable; and (4) expert assessment of available data for districts for which no prevalence estimates were available. Internally age- and sex-standardized data represented 1,355 districts and contributed 662 thousand cases (95% confidence interval [CI] 324 thousand-1.1 million) to the global total. Age- and sex-standardized district-level prevalence estimates differed from raw estimates by a mean factor of 0.45 (range 0.03-2.28). Previously non- stratified estimates for 398 districts, adjusted by ×0.45, contributed a further 411 thousand cases (95% CI 283-557 thousand). Eight countries retained previous estimates, contributing 848 thousand cases (95% CI 225 thousand-1.7 million). New expert assessments in 14 countries contributed 862 thousand cases (95% CI 228 thousand-1.7 million). The global trichiasis burden in 2016 was 2.8 million cases (95% CI 1.1-5.2 million). The 2016 estimate is lower than previous estimates, probably due to more and better data; scale-up of trichiasis management services; and reductions in incidence due to lower active trachoma prevalence.

Sections du résumé

BACKGROUND
Trichiasis is present when one or more eyelashes touches the eye. Uncorrected, it can cause blindness. Accurate estimates of numbers affected, and their geographical distribution, help guide resource allocation.
METHODS
We obtained district-level trichiasis prevalence estimates in adults for 44 endemic and previously-endemic countries. We used (1) the most recent data for a district, if more than one estimate was available; (2) age- and sex-standardized corrections of historic estimates, where raw data were available; (3) historic estimates adjusted using a mean adjustment factor for districts where raw data were unavailable; and (4) expert assessment of available data for districts for which no prevalence estimates were available.
FINDINGS
Internally age- and sex-standardized data represented 1,355 districts and contributed 662 thousand cases (95% confidence interval [CI] 324 thousand-1.1 million) to the global total. Age- and sex-standardized district-level prevalence estimates differed from raw estimates by a mean factor of 0.45 (range 0.03-2.28). Previously non- stratified estimates for 398 districts, adjusted by ×0.45, contributed a further 411 thousand cases (95% CI 283-557 thousand). Eight countries retained previous estimates, contributing 848 thousand cases (95% CI 225 thousand-1.7 million). New expert assessments in 14 countries contributed 862 thousand cases (95% CI 228 thousand-1.7 million). The global trichiasis burden in 2016 was 2.8 million cases (95% CI 1.1-5.2 million).
INTERPRETATION
The 2016 estimate is lower than previous estimates, probably due to more and better data; scale-up of trichiasis management services; and reductions in incidence due to lower active trachoma prevalence.

Identifiants

pubmed: 31765415
doi: 10.1371/journal.pntd.0007835
pii: PNTD-D-18-00529
pmc: PMC6901231
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0007835

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Negl Trop Dis. 2017 Jan 23;11(1):e0005277
pubmed: 28114364
Ophthalmic Epidemiol. 2016;23(sup1):84-93
pubmed: 27918229
Ophthalmic Epidemiol. 2016;23(sup1):94-99
pubmed: 27918232
Ophthalmic Epidemiol. 2016;23(sup1):55-62
pubmed: 27775463
Ophthalmic Epidemiol. 2016;23(sup1):22-31
pubmed: 27893297
Ophthalmic Epidemiol. 2016;23(sup1):46-54
pubmed: 27918227
Ophthalmic Epidemiol. 2016 Dec;23(6):406-411
pubmed: 27726459
Trans R Soc Trop Med Hyg. 2008 May;102(5):432-8
pubmed: 18394663
Ophthalmic Epidemiol. 2017 Aug;24(4):265-273
pubmed: 28441120
Ophthalmic Epidemiol. 2016;23(sup1):70-76
pubmed: 27918248
Ophthalmic Epidemiol. 2016;23(sup1):3-7
pubmed: 27726472
Ophthalmic Epidemiol. 2016;23(sup1):77-83
pubmed: 27918222
Am J Trop Med Hyg. 2018 Oct;99(4):858-863
pubmed: 30039782
Ophthalmic Epidemiol. 2016 Dec;23(6):381-391
pubmed: 27841721
Ophthalmic Epidemiol. 2015;22(3):176-83
pubmed: 26158575
Ophthalmic Epidemiol. 2018 Dec;25(sup1):192-200
pubmed: 28850014
Ophthalmic Epidemiol. 2016 Dec;23(6):412-417
pubmed: 27775454
Clin Microbiol Rev. 2004 Oct;17(4):982-1011, table of contents
pubmed: 15489358
Ophthalmic Epidemiol. 2016;23(sup1):39-45
pubmed: 27846369
Br J Ophthalmol. 2018 Oct;102(10):1324-1327
pubmed: 29907634
Ophthalmic Epidemiol. 2016;23(sup1):32-38
pubmed: 27726469
Ophthalmic Epidemiol. 2015;22(3):214-25
pubmed: 26158580
Invest Ophthalmol Vis Sci. 2011 Oct 10;52(11):7974-80
pubmed: 21896855
Int Health. 2014 Dec;6(4):291-7
pubmed: 25125577
Wkly Epidemiol Rec. 2012 Apr 27;87(17):161-8
pubmed: 22574352
Wkly Epidemiol Rec. 2014 Sep 26;89(39):421-8
pubmed: 25275153
Ophthalmic Epidemiol. 2016;23(sup1):63-69
pubmed: 27918223
Ophthalmic Epidemiol. 2016;23(sup1):8-14
pubmed: 27846362
Ophthalmic Epidemiol. 2016 Dec;23(6):392-405
pubmed: 27820657
Trans R Soc Trop Med Hyg. 2007 Oct;101(10):996-1003
pubmed: 17658570
PLoS Negl Trop Dis. 2016 Jul 12;10(7):e0004798
pubmed: 27404379
PLoS Negl Trop Dis. 2017 Jan 24;11(1):e0005267
pubmed: 28118354
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):847-52
pubmed: 16505016
Ophthalmic Epidemiol. 2016;23(sup1):15-21
pubmed: 27937043
Trans Ophthalmol Soc U K. 1975 Apr;95(1):16-33
pubmed: 775692
Ophthalmic Epidemiol. 2018 Dec;25(sup1):201-210
pubmed: 28910562
Ophthalmic Epidemiol. 2016 Dec;23(6):373-380
pubmed: 27775455
Bull World Health Organ. 1987;65(4):477-83
pubmed: 3500800
Lancet. 2003 Jul 19;362(9379):223-9
pubmed: 12885486
Br J Ophthalmol. 2009 May;93(5):563-8
pubmed: 19098034

Auteurs

Rebecca M Flueckiger (RM)

Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Paul Courtright (P)

Kilimanjaro Centre for Community Ophthalmology, Division of Ophthalmology, University of Cape Town, Cape Town, South Africa.

Mariamo Abdala (M)

Ministerio da Saude, National Ophthalmology Program, Maputo, Mozambique.

Amza Abdou (A)

Ministère de la Santé et de la population, Niamey, Niger.

Zaid Abdulnafea (Z)

Ministry of Health, Baghdad, Iraq.

Tawfik K Al-Khatib (TK)

National Eye Health Programme, Ministry of Public Health and Population, Sana'a, Yemen.

Khaled Amer (K)

Ministry of Health, Cairo, Egypt.

Olga Nelson Amiel (ON)

Ministerio da Saude, Maputo, Mozambique.

Sossinou Awoussi (S)

Ministère de la Santé, Lomé, Togo.

Ana Bakhtiari (A)

The Task Force for Global Health, Atlanta, GA, USA.

Wilfried Batcho (W)

Ministère de la Santé, Cotonou, Benin.

Assumpta Lucienne Bella (AL)

Ministère de la Santé, Yaoundé, Cameroun.

Kamal Hashim Bennawi (KH)

Prevention of Blindness Program, Khartoum, Sudan.

Simon J Brooker (SJ)

Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Global Health, Neglected Tropical Diseases, Bill & Melinda Gates Foundation, Seattle, USA.

Brian K Chu (BK)

The Task Force for Global Health, Atlanta, GA, USA.

Michael Dejene (M)

Michael Dejene Public Health Consultancy Services, Addis Ababa, Ethiopia.

Djore Dezoumbe (D)

Ministère de la Santé, N'Djamena, Chad.

Balgesa Elkheir Elshafie (BE)

Trachoma Control Program, National Ministry of Health, Khartoum, Sudan.

Aba Ange Elvis (AA)

Programme National de la Santé Oculaire et de la lutte contre l'Onchocercose, Abidjan, Côte d'Ivoire.

Djouma Nembot Fabrice (DN)

Ministère de la Santé, Yaoundé, Cameroun.

Fatma Juma Omar (FJ)

Ministry of Health, Zanzibar, United Republic of Tanzania.

Missamou François (M)

Bureau des Maladies Oculaires, Ministère de la Santé, Kinshasa, Democratic Republic of the Congo.

Drabo François (D)

Programme national de lutte contre les maladies tropicales négligées (PNMTN), Ouagadougou, Burkina Faso.

Jambi Garap (J)

National Department of Health, Port Moresby, Papua New Guinea.

Michael Gichangi (M)

Ministry of Health, Nairobi, Kenya.

André Goepogui (A)

Programme National de Lutte Contre l'Onchocercose et la Cécité et les Maladies Tropicales Négligées, Conakry, Guinea.

Jaouad Hammou (J)

Ministry of Health, Rabat, Morocco.

Boubacar Kadri (B)

Ministère de la Santé et de la population, Niamey, Niger.

George Kabona (G)

Ministry of Health, Dar es Salaam, United Republic of Tanzania.

Martin Kabore (M)

l'unité d'élimination du trachome, PNMTN, Ouagadougou, Burkina Faso.

Khumbo Kalua (K)

Department of Ophthalmology, University of Malawi, College of Medicine, Blantyre, Malawi.

Mathias Kamugisha (M)

National Institute for Medical Research, Dar es Salaam, United Republic of Tanzania.

Biruck Kebede (B)

Federal Ministry of Health, Addis Ababa, Ethiopia.

Kaba Keita (K)

Programme National de Lutte Contre l'Onchocercose et la Cécité et les Maladies Tropicales Négligées, Conakry, Guinea.

Asad Aslam Khan (AA)

Ministry of Health, Islamabad, Pakistan.

Genet Kiflu (G)

Federal Ministry of Health, Addis Ababa, Ethiopia.

Makoy Yibi (M)

Ministry of Health, South Sudan.

Garae Mackline (G)

Ministry of Health, Port Vila, Vanuatu.

Colin Macleod (C)

Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Portia Manangazira (P)

Department of Epidemiology and Disease Control, Ministry of Health & Child Welfare, Harare, Zimbabwe.

Michael P Masika (MP)

Ministry of Health, Lilongwe, Malawi.

Marilia Massangaie (M)

Ministerio da Saude, Department of Neglected Tropical Diseases, Maputo, Mozambique.

Takafira Mduluza (T)

Department of Biochemistry, University of Zimbabwe, Harare, Zimbabwe.

Nabicassa Meno (N)

Ministère de la Santé, Bissau, Guinea-Bissau.

Nicholas Midzi (N)

Department of Medical Microbiology, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

Abdallahi Ould Minnih (AO)

Minister de la Sante, Nouakchott, Mauritania.

Sailesh Mishra (S)

Nepal Netra Jyoti Sangh, Kathmandu, Nepal.

Caleb Mpyet (C)

Sightsavers Nigeria, Kaduna, Nigeria & Department of Ophthalmology, Jos University, Jos, Nigeria.

Nicholas Muraguri (N)

Ministry of Health, Nairobi, Kenya.

Upendo Mwingira (U)

Ministry of Health, Dar es Salaam, United Republic of Tanzania.

Beido Nassirou (B)

Ministère de la Santé et de la population, Niamey, Niger.

Jean Ndjemba (J)

Bureau des Maladies Oculaires, Ministère de la Santé, Kinshasa, Democratic Republic of the Congo.

Cece Nieba (C)

Programme National de Lutte Contre l'Onchocercose et la Cécité et les Maladies Tropicales Négligées, Conakry, Guinea.

Jeremiah Ngondi (J)

RTI International, Dar es Salaam, United Republic of Tanzania.

Nicholas Olobio (N)

Nigeria Federal Ministry of Health, Abuja, Nigeria.

Alex Pavluck (A)

RTI International, Washington DC, USA.

Isaac Phiri (I)

Department of Epidemiology and Disease Control, Ministry of Health & Child Welfare, Harare, Zimbabwe.

Rachel Pullan (R)

Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Babar Qureshi (B)

Christian Blind Mission, Bensheim, Germany.

Boubacar Sarr (B)

Ministère de la santé et de l'Action Sociale, Dakar, Senegal.

Do Seiha (D)

Prevention of Blindness Programme, Ministry of Health, Phnom Penh, Cambodia.

Gloria Marina Serrano Chávez (GMS)

Ministry of Health, Guatemala City, Guatemala.

Shekhar Sharma (S)

Ministry of Health, Kathmandu, Nepal.

Siphetthavong Sisaleumsak (S)

National Ophthalmology Centre, Vientiane, Lao People's Democratic Republic.

Khamphoua Southisombath (K)

National Program for the Prevention of Blindness, Ministry of Health, Vientiane, Lao People's Democratic Republic.

Gretchen Stevens (G)

Department of Information, Evidence and Research, World Health Organization, Geneva, Switzerland.

Andeberhan Tesfazion Woldendrias (AT)

Department of Public Health, Ministry of Health, Asmara, Eritrea.

Lamine Traoré (L)

Ministère de la Santé, Bamako, Mali.

Patrick Turyaguma (P)

Trachoma Program, Ministry of Health, Kampala, Uganda.

Rebecca Willis (R)

The Task Force for Global Health, Atlanta, GA, USA.

Georges Yaya (G)

Ministère de la Santé Publique, Bangui, Central African Republic.

Souleymane Yeo (S)

Programme National de la Santé Oculaire et de la lutte contre l'Onchocercose, Abidjan, Côte d'Ivoire.

Francisco Zambroni (F)

Ministry of Health, Guatemala City, Guatemala.

Jialiang Zhao (J)

Department of Ophthalmology, Peking Union Medical Colllege Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Anthony W Solomon (AW)

Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH